Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

To Evaluate Immune Response to a Hepatitis B Vaccine (Engerix™-B ) Challenge Dose in Healthy Subjects Who Received GSK Biologicals' Hepatitis B Vaccine (Engerix™-B ) Approximately 20 Years Ago as Primary Vaccination at 0, 1, 2 and 12 Months.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00456625
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:21.251532+00:00
Published At
2009-05-15T00:00:00+00:00
Record Updated At
2016-12-16
Results Posted At
2009-05-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-12-16"
protocolSection.identificationModule.nctId
"NCT00456625"
protocolSection.identificationModule.officialTitle
"To Evaluate Immune Response to a Hepatitis B Vaccine (Engerix\u2122-B ) Challenge Dose in Healthy Subjects Who Received GSK Biologicals\u0027 Hepatitis B Vaccine (Engerix\u2122-B ) Approximately 20 Years Ago as Primary Vaccination at 0, 1, 2 and 12 Months."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2009-05-15"

Study condition terms

  • Hepatitis B (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.